このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Integra LifeSciences Holdings 過去の業績
過去 基準チェック /16
Integra LifeSciences Holdingsは、平均年間10.9%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間8.7% 1.5%収益成長率で 成長しています。 Integra LifeSciences Holdingsの自己資本利益率は2.5%であり、純利益率は2.6%です。
主要情報
10.9%
収益成長率
11.7%
EPS成長率
| Medical Equipment 業界の成長 | 8.9% |
| 収益成長率 | 1.5% |
| 株主資本利益率 | 2.5% |
| ネット・マージン | 2.6% |
| 前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01
Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 06FDA labels recall of intracranial pressure monitors by Integra as most serious
Aug 31Integra Lifesciences voluntarily recalls pressure monitors, lowers revenue, profit guidance
Aug 24Returns At Integra LifeSciences Holdings (NASDAQ:IART) Appear To Be Weighed Down
Aug 23Integra LifeSciences founder/former CEO dies
Aug 16収支内訳
収支内訳
Integra LifeSciences Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 1,530 | 40 | 595 | 81 |
| 31 Dec 23 | 1,542 | 68 | 593 | 83 |
| 30 Sep 23 | 1,543 | 101 | 594 | 84 |
| 30 Jun 23 | 1,545 | 131 | 614 | 87 |
| 31 Mar 23 | 1,562 | 172 | 615 | 84 |
| 31 Dec 22 | 1,558 | 181 | 614 | 82 |
| 30 Sep 22 | 1,565 | 173 | 625 | 81 |
| 30 Jun 22 | 1,567 | 166 | 619 | 82 |
| 31 Mar 22 | 1,559 | 157 | 614 | 79 |
| 31 Dec 21 | 1,542 | 169 | 637 | 93 |
| 30 Sep 21 | 1,526 | 216 | 604 | 74 |
| 30 Jun 21 | 1,509 | 206 | 597 | 72 |
| 31 Mar 21 | 1,378 | 170 | 555 | 68 |
| 31 Dec 20 | 1,372 | 134 | 595 | 77 |
| 30 Sep 20 | 1,378 | 56 | 573 | 77 |
| 30 Jun 20 | 1,387 | -3 | 584 | 78 |
| 31 Mar 20 | 1,512 | 27 | 623 | 81 |
| 31 Dec 19 | 1,518 | 50 | 688 | 80 |
| 30 Sep 19 | 1,506 | 60 | 608 | 74 |
| 30 Jun 19 | 1,493 | 101 | 610 | 75 |
| 31 Mar 19 | 1,475 | 83 | 608 | 76 |
| 31 Dec 18 | 1,472 | 61 | 691 | 78 |
| 30 Sep 18 | 1,458 | 80 | 607 | 75 |
| 30 Jun 18 | 1,371 | 70 | 572 | 70 |
| 31 Mar 18 | 1,287 | 69 | 546 | 66 |
| 31 Dec 17 | 1,188 | 65 | 517 | 63 |
| 30 Sep 17 | 1,075 | 49 | 475 | 60 |
| 30 Jun 17 | 1,047 | 66 | 460 | 60 |
| 31 Mar 17 | 1,014 | 68 | 446 | 59 |
| 31 Dec 16 | 992 | 75 | 431 | 58 |
| 30 Sep 16 | 985 | 61 | 426 | 57 |
| 30 Jun 16 | 958 | 9 | 415 | 56 |
| 31 Mar 16 | 919 | 9 | 395 | 53 |
| 31 Dec 15 | 883 | 7 | 377 | 50 |
| 30 Sep 15 | 854 | 12 | 360 | 47 |
| 30 Jun 15 | 827 | 53 | 346 | 44 |
| 31 Mar 15 | 782 | 46 | 325 | 42 |
| 31 Dec 14 | 797 | 36 | 335 | 43 |
| 30 Sep 14 | 798 | 30 | 345 | 47 |
| 30 Jun 14 | 814 | -10 | 356 | 49 |
| 31 Mar 14 | 855 | -13 | 380 | 51 |
| 31 Dec 13 | 697 | 22 | 305 | 42 |
| 30 Sep 13 | 830 | -22 | 373 | 50 |
質の高い収益: IARTには$160.4M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が31st March, 2024に影響を及ぼしています。
利益率の向上: IARTの現在の純利益率 (2.6%)は、昨年(11%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: IARTの収益は過去 5 年間で年間10.9%増加しました。
成長の加速: IARTは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: IARTは過去 1 年間で収益成長率がマイナス ( -76.6% ) となったため、 Medical Equipment業界平均 ( 2.4% ) と比較することが困難です。
株主資本利益率
高いROE: IARTの 自己資本利益率 ( 2.5% ) は 低い とみなされます。